Tracking Peptide Results: Biomarkers & Metrics

"I think it's working" is not data. If you're investing time and money in peptide therapy, you need objective ways to measure whether it's actually doing what you intend. The right biomarkers and metrics turn guesswork into informed decisions — and they protect you from continuing a protocol that isn't working or missing early warning signs of problems.

This guide covers what to measure, how to measure it, how often, and what the numbers mean.

Why Tracking Matters
Blood Work: The Core Biomarkers
Body Composition Tracking
Sleep Metrics
Cognitive Assessments
Skin and Appearance Measurements
Inflammation and Immune Markers
How Often to Test
Working With Your Doctor on Monitoring
Building Your Personal Tracking Dashboard
Frequently Asked Questions
The Bottom Line
References

Why Tracking Matters

Three reasons tracking transforms peptide therapy from trial-and-error into precision optimization:

1. Confirmation. You need to know if the peptide is actually affecting the target pathway. If CJC-1295/Ipamorelin isn't raising your IGF-1, something is wrong — bad product, incorrect dosing, or a physiological issue. Without measuring IGF-1, you'd never know.

2. Safety. Peptides can push biomarkers outside healthy ranges. Chronically elevated IGF-1 carries theoretical cancer risk. GH peptides can impair insulin sensitivity. GLP-1 agonists can cause subclinical dehydration and electrolyte imbalances. Monitoring catches these issues before they become problems.

3. Optimization. Your optimal dose isn't what a Reddit post says. It's the dose that produces the best biomarker response with the fewest side effects in YOUR body. Data-driven dose adjustments produce better outcomes than fixed protocols.

Blood Work: The Core Biomarkers

For Growth Hormone Peptide Users (CJC-1295, Ipamorelin, Sermorelin, Tesamorelin)

IGF-1 (Insulin-like Growth Factor 1)

What it tells you: IGF-1 is the primary downstream marker of growth hormone activity. It reflects your average GH status over the preceding weeks (similar to how HbA1c reflects average blood sugar). If your GH peptide is working, IGF-1 should increase.
Target range: Upper third of the age-adjusted normal range. For most adults, this means 200-300 ng/mL. Going above 350 ng/mL may increase risk without proportional benefit.
Red flag: IGF-1 above 400 ng/mL warrants dose reduction. IGF-1 that doesn't budge from baseline after 8 weeks suggests the peptide isn't working.
Frequency: Baseline, 8 weeks, then every 3-6 months on protocol.

Fasting Insulin and Fasting Glucose

What it tells you: GH and insulin are antagonistic. GH peptides can increase insulin resistance over time. Monitoring fasting insulin and glucose catches this early.
Target range: Fasting insulin <10 mU/L is ideal. Fasting glucose 70-99 mg/dL is normal. HOMA-IR (calculated from fasting insulin and glucose) below 1.5 is optimal.
Red flag: Fasting insulin rising above 15 mU/L, fasting glucose creeping above 100, or HOMA-IR above 2.5.
Frequency: Baseline and every 8-12 weeks on GH peptides.

HbA1c (Glycated Hemoglobin)

What it tells you: 3-month average blood glucose. More stable than spot checks.
Target range: Below 5.7% (normal). 5.7-6.4% indicates pre-diabetes. Above 6.5% is diabetes.
Why it matters for peptide users: GH peptides can shift glucose metabolism. GLP-1 agonists should lower HbA1c. Tesamorelin has been shown to slightly increase HbA1c in some patients.
Frequency: Baseline and every 6 months.

For Anti-Inflammatory Peptide Users (BPC-157, KPV, Thymosin Alpha-1)

hs-CRP (High-Sensitivity C-Reactive Protein)

What it tells you: General systemic inflammation. Produced by the liver in response to inflammatory signals. One of the most validated inflammatory markers.
Target range: Below 1.0 mg/L is optimal. 1.0-3.0 mg/L is average risk. Above 3.0 mg/L indicates elevated inflammation.
What to expect: If your anti-inflammatory peptide protocol is working, hs-CRP should trend downward over 4-8 weeks.
Frequency: Baseline, 8 weeks, then every 3-6 months.

IL-6 (Interleukin-6)

What it tells you: A specific inflammatory cytokine that drives many age-related inflammatory processes. More specific than CRP for certain types of inflammation.
Target range: Below 1.8 pg/mL is normal. Elevated levels indicate active inflammation.
Frequency: Baseline and 8 weeks (more expensive than hs-CRP, so less frequent testing is practical).

TNF-alpha (Tumor Necrosis Factor-alpha)

What it tells you: A primary inflammatory cytokine involved in systemic inflammation. Elevated in autoimmune conditions, chronic infection, and inflammaging.
Target range: Below 8.1 pg/mL is normal.
Frequency: Baseline and follow-up as needed.

For All Peptide Users: The Baseline Panel

Every peptide user should get this before starting any protocol:

Test	Why	Normal Range
Complete metabolic panel (CMP)	Liver/kidney function, electrolytes	Lab-specific ranges
Complete blood count (CBC)	Overall health, immune status	Lab-specific ranges
Fasting insulin	Metabolic baseline	<10 mU/L ideal
Fasting glucose	Metabolic baseline	70-99 mg/dL
HbA1c	3-month glucose average	<5.7%
IGF-1	GH axis baseline	Age-adjusted
hs-CRP	Inflammatory baseline	<1.0 mg/L ideal
TSH, Free T3, Free T4	Thyroid function	Lab-specific
Testosterone (men) / Estradiol (women)	Hormonal baseline	Age/sex-specific
DHEA-S	Adrenal function	Age/sex-specific
Vitamin D (25-OH)	Vitamin D status	40-60 ng/mL optimal
Lipid panel	Cardiovascular baseline	LDL <100, HDL >40/50

Where to get blood work: Your physician can order these tests. Direct-to-consumer options (Marek Health, Ulta Lab Tests, Quest Direct, LabCorp patient services) allow you to order without a prescription at $100-400 for a comprehensive panel.

Body Composition Tracking

Peptides that affect body composition (GH peptides, GLP-1 agonists) need body composition data — not just scale weight.

DEXA Scan (Gold Standard)

What it is: Dual-energy X-ray absorptiometry. Measures lean mass, fat mass, bone mineral density, and visceral adipose tissue with high precision.

Why it's best: DEXA gives you exact numbers for lean mass vs. fat mass, region by region. Scale weight doesn't distinguish between 5 lbs of fat loss and 3 lbs of muscle gain and 2 lbs of water loss. DEXA does.

Accuracy: ±1-2% for body fat percentage. Consistent enough to detect meaningful changes over 8-12 weeks.

Cost: $75-200 per scan.

Frequency: Baseline, 12 weeks, then every 3-6 months on body composition protocols.

Bioelectrical Impedance Analysis (BIA)

What it is: Most "smart" scales use BIA — sending a small electrical current through the body to estimate composition.

Pros: Cheap ($30-100 for a home scale), convenient, daily tracking possible.

Cons: Accuracy fluctuates with hydration status, recent meals, exercise, and time of day. Can be off by 3-5% for body fat percentage. Use it for trends, not absolute numbers.

Best practice: Weigh at the same time daily (morning, fasted, after using the bathroom). Track the 7-day rolling average, not daily fluctuations.

Waist Circumference

The simplest body composition metric and one of the most predictive for health outcomes. Visceral fat loss shows up in waist measurements before it shows on a scale.

How to measure: Stand, exhale normally, measure at the belly button level with a cloth tape measure. Same time, same conditions each time.

Target: Men below 40 inches, women below 35 inches. Decreasing waist circumference on GH peptides or GLP-1 agonists confirms visceral fat loss.

Frequency: Weekly.

Progress Photography

Consistent photos under the same lighting, angle, and time of day provide visual evidence that numbers can't capture.

Protocol: Front, side, and back photos. Same location, same lighting, same clothing. First thing in the morning, before eating. Take a set every 2-4 weeks.

Sleep Metrics

Sleep quality is both a goal of peptide therapy (GH peptides improve deep sleep) and a foundation that supports all other peptide effects.

Wearable Tracking

Oura Ring, WHOOP, Apple Watch, Garmin: All provide sleep staging (light, deep, REM), total sleep time, sleep onset latency, and nighttime heart rate.

Key metrics to track on GH peptides:

Deep sleep duration: Should increase. GH is released during deep sleep, and GH peptides often increase deep sleep time by 15-30%.
Sleep onset latency: How long it takes to fall asleep. Should decrease or stay stable.
Total sleep time: Should be 7-9 hours.
Heart rate variability (HRV): Higher HRV generally indicates better recovery and lower stress. Should trend upward with good sleep and reduced inflammation.
Resting heart rate: Should be stable or trending downward (lower = better cardiovascular fitness and recovery).

Accuracy note: Consumer wearables are moderately accurate for total sleep time and sleep efficiency but less reliable for sleep staging. Use them for trends over weeks, not single-night analysis. For more peptides that affect sleep, see best peptides for sleep.

Subjective Sleep Assessment

Rate daily on a 1-10 scale:

How refreshed do you feel upon waking?
How would you rate overall sleep quality?
Any nighttime awakenings?

Combine with wearable data for the most complete picture.

Cognitive Assessments

For users of nootropic peptides (Semax, Selank) or GH peptides (which may improve cognitive function), standardized cognitive testing provides objective data.

Standardized Testing Platforms

Cambridge Brain Sciences (cambridgebrainsciences.com):

Free basic testing, paid for advanced
Tests: spatial memory, verbal reasoning, concentration
Takes 10-15 minutes
Normed against large populations

BrainHQ (brainhq.com):

Developed by neuroscientists
Measures processing speed, attention, memory, navigation
Tracks improvement over time

Quantified Mind (quantified-mind.com):

Designed for self-experimenters
Custom test batteries
Statistical analysis of your data

What to Measure

Domain	What It Tells You	Test Example
Working memory	Short-term information manipulation	Digit span, n-back
Processing speed	How fast you think	Simple reaction time
Executive function	Planning, decision-making	Stroop test, Tower of London
Verbal fluency	Word recall and language production	Category fluency
Attention/focus	Sustained concentration	Continuous performance test

Frequency: Baseline (average of 3 sessions over 1 week), then weekly during the first 6 weeks of a nootropic protocol. Monthly thereafter.

Subjective Cognitive Tracking

Daily ratings (1-10):

Mental clarity
Focus/concentration
Memory recall
Motivation/drive
Anxiety level (for Selank users)
Creativity/problem-solving

See our guide on best peptides for cognitive enhancement for expectations and timelines.

Skin and Appearance Measurements

For GHK-Cu users and those tracking skin aging effects of GH peptides.

Photography Protocol

Consistent photography is the most accessible skin tracking method.

Equipment: Smartphone camera is fine. The key is consistency, not camera quality.

Protocol:

Same location every time
Same lighting (avoid window light, which changes with weather/time)
Same distance from camera (mark a spot on the floor)
Same facial expression (relaxed, neutral)
Clean, dry skin (no makeup)
Take front, 45-degree angle, and profile shots
Same time of day (morning, before skincare products)

Frequency: Every 2 weeks for the first 12 weeks, then monthly.

Clinical Skin Measurements (If Available)

Cutometry: Measures skin elasticity. Available at dermatology offices and some skincare clinics.
Corneometry: Measures skin hydration.
VISIA skin analysis: Computer-analyzed photography that quantifies wrinkles, pores, UV damage, and texture.
Cost: $50-200 per session, depending on the analysis type.

Subjective Skin Assessment

Weekly ratings:

Skin firmness (1-10)
Wrinkle depth (1-10, with reference photos)
Skin hydration/plumpness (1-10)
Skin texture/smoothness (1-10)
Healing speed (for any cuts, abrasions)

Inflammation and Immune Markers

For users of anti-inflammatory peptides (BPC-157, KPV) and immune-modulating peptides (Thymosin Alpha-1).

Beyond hs-CRP

Erythrocyte Sedimentation Rate (ESR):

Another general inflammation marker
Complements hs-CRP (they can diverge, giving different inflammation information)
Normal: below 20 mm/hr for men, below 30 mm/hr for women

Ferritin:

While primarily an iron marker, ferritin is also an acute-phase reactant that rises with inflammation
Useful for distinguishing iron-related ferritin elevation from inflammatory elevation

Fibrinogen:

Coagulation protein that increases with inflammation
Relevant for cardiovascular risk assessment alongside anti-inflammatory peptide monitoring

Immune Cell Subsets (for Thymosin Alpha-1 users):

CD4/CD8 ratio (T-cell balance)
Natural killer cell count and activity
Total lymphocyte count
These require specialized flow cytometry panels — discuss with your physician

How Often to Test

Testing Schedule

Timepoint	What to Test	Why
Pre-protocol (baseline)	Full panel (all applicable markers)	Establish starting point
Week 4	Subjective tracking review, basic blood work if symptoms warrant	Early problem detection
Week 8	Comprehensive recheck (IGF-1, metabolic, inflammatory markers)	Confirm peptide is working, adjust dose
Week 12	DEXA scan (if body composition goal), cognitive testing	Full effect evaluation
Every 3-6 months (ongoing)	Comprehensive blood panel	Ongoing monitoring
Annually	Full comprehensive panel + DEXA + cognitive battery	Annual health assessment

When to Test Early

Get blood work before your scheduled check if:

You experience unexpected side effects (fatigue, joint pain, mood changes)
You feel significantly worse on the peptide
You have new symptoms that weren't present before starting
You're adding a new peptide to the protocol

Working With Your Doctor on Monitoring

Bring to each appointment:

Your tracking spreadsheet or app data
Blood work results (with trends highlighted)
A list of peptides, doses, and timing
Any side effects or concerns
Your goals and whether you're meeting them

What to Ask Your Doctor

"Are my biomarkers trending in the right direction?"
"Is my IGF-1 in a safe range, or should we adjust the dose?"
"Are there any markers we should add to my panel based on what we're seeing?"
"How does my current metabolic status affect my peptide protocol?"
"When should I repeat this blood work?"

Finding a Monitoring-Savvy Practitioner

Not all doctors are familiar with peptide therapy monitoring. Look for:

Anti-aging medicine specialists (A4M training)
Functional medicine practitioners
Endocrinologists (for GH peptide monitoring)
Integrative medicine doctors

See our guide on choosing a peptide therapy clinic and talking to your doctor about peptides.

Building Your Personal Tracking Dashboard

The Minimum Viable Tracking System

For people who won't use a spreadsheet, the bare minimum:

A journal — Date, peptide, dose, time. One line for how you feel (energy, sleep, mood on 1-10). Note any side effects.
Blood work — Baseline and 8-week recheck. Print results and keep them together.
Scale weight — Weekly, same conditions. Write it in the journal.

The Optimal Tracking System

For people who want data-driven optimization:

Weekly inputs:

Daily peptide log (dose, time, injection site)
Daily subjective ratings (energy, sleep, mood, focus, recovery — all 1-10)
Weekly body weight and waist circumference
Weekly sleep data summary from wearable
Weekly cognitive test scores (if using nootropics)

Monthly inputs:

Progress photos
Body composition measurement (BIA scale or DEXA)
Review of trends and protocol adjustments

Quarterly inputs:

Comprehensive blood work
Full assessment of goals vs. outcomes
Protocol optimization meeting with practitioner

Tools

Spreadsheet (Google Sheets/Excel): Maximum flexibility, free. Create columns for date, peptide, dose, and each metric.
Apple Health / Google Fit: Aggregate wearable data automatically.
Cronometer: Track nutrition alongside peptide protocols (useful for ensuring protein targets are met).
DEXA scan tracking: Most facilities provide reports that show changes from your previous scan.

Frequently Asked Questions

What's the most important biomarker to track on peptide therapy? It depends on your peptide. For GH peptides: IGF-1 (confirms the peptide is working) and fasting insulin (catches insulin resistance early). For anti-inflammatory peptides: hs-CRP. For GLP-1 agonists: HbA1c and body weight. If you had to pick one universal marker: fasting insulin. It reflects metabolic health broadly and is relevant to nearly every peptide category.

Can I track peptide results without blood work? You can track subjective improvements and body composition without blood work. But you can't confirm the peptide is actually affecting the target pathway, and you can't monitor for safety issues. Blood work is strongly recommended — especially for GH peptides and GLP-1 agonists. The beginner's guide to peptide therapy covers minimum monitoring requirements.

How much does a full monitoring program cost per year? Basic monitoring (4 blood panels per year + 2 DEXA scans): $1,000-2,500. Comprehensive monitoring (adding cognitive testing, specialist consultations, and advanced markers): $2,500-5,000. This should be factored into your total peptide therapy budget.

What if my blood work looks worse on peptides? Stop the peptide and consult your physician. Specifically: if IGF-1 is excessively elevated (>400 ng/mL), reduce GH peptide dose. If fasting insulin is rising, reassess GH peptide use or add metformin (with physician guidance). If liver enzymes are elevated, stop all peptides and investigate. Any unexpected biomarker changes warrant medical evaluation before continuing.

Do I need to fast before blood work? For the most accurate results: fast for 10-12 hours before blood draws. This is required for fasting insulin, fasting glucose, and lipid panels. HbA1c, hs-CRP, and IGF-1 are not fasting-dependent but are typically drawn at the same time for convenience. Schedule blood draws first thing in the morning.

How do wearable sleep trackers compare to clinical sleep studies? Consumer wearables (Oura, WHOOP, Apple Watch) are 60-80% accurate for sleep staging compared to polysomnography (the clinical gold standard). They're good enough for tracking trends over time but not precise enough for clinical diagnosis. If you suspect a sleep disorder (sleep apnea, for example), get a clinical sleep study — no wearable replaces it.

The Bottom Line

What gets measured gets managed. Peptide therapy without tracking is hope-based medicine. Peptide therapy with tracking is data-driven optimization.

Start with baseline blood work. Track IGF-1 for GH peptides, inflammatory markers for anti-inflammatory peptides, and metabolic markers for everyone. Add body composition, sleep, and cognitive measurements based on your goals. Review data every 8 weeks. Adjust based on what the numbers say, not what you feel.

The investment in monitoring pays for itself. It confirms when peptides are working (so you can continue confidently), catches problems early (so you can adjust before harm), and guides dose optimization (so you get the most value from every dollar spent).

References

Junnila, R.K., et al. "The GH/IGF-1 axis in ageing and longevity." Nature Reviews Endocrinology, vol. 9, no. 6, 2013, pp. 366-376.
Matthews, D.R., et al. "Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man." Diabetologia, vol. 28, 1985, pp. 412-419.
Ridker, P.M. "High-sensitivity C-reactive protein: potential adjunct for global risk assessment in the primary prevention of cardiovascular disease." Circulation, vol. 103, no. 13, 2001, pp. 1813-1818.
Shepherd, J.A., et al. "Body composition by DXA." Bone, vol. 104, 2017, pp. 101-105.
Mantua, J., et al. "Reliability of sleep measures from four personal health monitoring devices compared to research-based actigraphy and polysomnography." Sensors, vol. 16, no. 5, 2016, 646.
Teichman, S.L., et al. "Prolonged stimulation of growth hormone and insulin-like growth factor I secretion by CJC-1295." Journal of Clinical Endocrinology & Metabolism, vol. 91, no. 3, 2006, pp. 799-805.
Falutz, J., et al. "Metabolic effects of a growth hormone-releasing factor in patients with HIV." New England Journal of Medicine, vol. 357, no. 23, 2007, pp. 2359-2370.
Hampshire, A., et al. "Fractionating human intelligence." Neuron, vol. 76, no. 6, 2012, pp. 1225-1237.

Table of Contents